MedPath

Vyome Therapeutics, Inc.

Vyome Therapeutics, Inc. logo
🇮🇳India
Ownership
Holding
Established
2010-01-01
Employees
11
Market Cap
-
Website
http://www.vyometx.com

Clinical Trials

1

Active:0
Completed:0

Trial Phases

1 Phases

Phase 2:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials

Phase 2
1 (100.0%)

Efficacy and Safety Study of VB-1953 Topical Gel for Inflammatory Facial Acne Vulgaris

Phase 2
Conditions
Acne Vulgaris
Interventions
Drug: VB-1953 - 2%
Drug: VB-1953 - 0% (Vehicle)
First Posted Date
2019-04-03
Last Posted Date
2019-10-01
Lead Sponsor
Vyome Therapeutics Inc.
Target Recruit Count
480
Registration Number
NCT03900676
Locations
🇺🇸

Vyome Therapeutics Inc., El Paso, Texas, United States

🇺🇸

Vyome Therapeutics Inc, Miami, Florida, United States

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.